Journal of the American Society of Nephrology : JASN
-
J. Am. Soc. Nephrol. · Jan 2021
Multicenter StudyAKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19.
AKI is a common sequela of coronavirus disease 2019 (COVID-19). However, few studies have focused on AKI treated with RRT (AKI-RRT). ⋯ AKI-RRT is common among critically ill patients with COVID-19 and is associated with a hospital mortality rate of >60%. Among those who survive to discharge, one in three still depends on RRT at discharge, and one in six remains RRT dependent 60 days after ICU admission.